Find generic entry opportunities
Proactively manage your pharmacy inventory
Anticipate generic drug launch
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Drug patents …
… from Kazakhstan to Kalamazoo
Manage your formulary budget
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
|Title:||Antiviral compositions and methods|
|Abstract:||Compositions containing 2',3'-dideoxycytidine and its triphosphates for use in treating retroviral infections including acquired immune deficiency syndrome (AIDS) are disclosed with preferred methods of treatment which provide protection against cytophatic effects of human immunodeficiency virus (HIV).|
|Inventor(s):||Mitsuya; Hiroaki (Rockville, MD), Broder; Samuel (Bethesda, MD)|
|Assignee:||The United States of America as represented by the Department of Health (Washington, DC)|
Patent Claim Types:|
see list of patent claims
|Use; Composition; Dosage form; Delivery;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Hong Kong||67995||► subscribe|
|European Patent Office||0216511||► subscribe||94C0015||Belgium||► subscribe|
|European Patent Office||0216511||► subscribe||SPC/GB95/003||United Kingdom||► subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.